Leonard Braden Michael Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
76
Insider Buys Sum
$18.47M
Insider Sells Quantity
51
Insider Sells Sum
$28.82M

Insider Activity of Leonard Braden Michael

According to the SEC Form 4 filings, Leonard Braden Michael, being in a position of

  1. 10 percent owner at Aclaris Therapeutics, Inc.,
    оver the last 12 months, has bought 4854052 shares for $5.59M, and sold 0 shares,
    over all time since 2024-06-11, has bought 4854052 shares for $5.59M, and sold 0 shares.

The largest purchase of all time was on 2024-08-14 and amounted to 1500000 shares of AN2 Therapeutics, Inc. for $1.56M.

The largest sale of all time was on 2022-12-29 and amounted to 3000000 shares of Retractable Technologies, Inc. for $4.8M.

Biography of Leonard Braden Michael

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $11,913,44733100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2025-04-02PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
15,209
0.0693%
$4.04$61,408-10.56%
2025-03-31PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
19,566
0.0942%
$4.38$85,668-12.36%
2025-03-27PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
16,593
0.0834%
$5.19$86,089-20.36%
2025-03-26PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
20,407
0.0981%
$5.04$102,841-18.55%
2025-03-20PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
30,600
0.1474%
$5.61$171,767-19.82%
2025-03-19PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
25,000
0.1096%
$4.94$123,390-14.31%
2025-03-18PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
62,341
0.2869%
$4.69$292,418-2.65%
2025-02-28PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
85,068
0.4042%
$4.60$391,015-2.49%
2025-02-27PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
86,802
0.4186%
$4.46$387,094+4.77%
2025-02-26PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
164,886
0.8826%
$4.01$660,979+14.81%
2024-08-14PurchaseAN2 Therapeutics, Inc.
ANTX
10 percent owner
1.5M
3.1264%
$1.04$1.56M+8.1%
2024-08-05PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
206,025
0.2901%
$1.24$256,357+46.98%
2024-08-02PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
167,544
0.2372%
$1.29$216,400+41.8%
2024-07-31PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
100,000
0.1421%
$1.33$132,640+35.07%
2024-07-30PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
173,730
0.2425%
$1.30$226,370+37.79%
2024-07-30PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
85,800
0.3983%
$7.15$613,470-17.86%
2024-07-22PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
17,716
0.0249%
$1.33$23,557+27.44%
2024-07-19PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
6,689
0.0092%
$1.30$8,696+28.03%
2024-07-18PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
130,317
0.1816%
$1.30$169,555+28.63%
2024-07-18PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
80,718
0.3739%
$9.11$735,737-33.65%
Total: 127
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.